Your browser doesn't support javascript.
loading
Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy.
Jacoberger-Foissac, Celia; Blake, Stephen J; Liu, Jing; McDonald, Elizabeth; Triscott, Hannah; Nakamura, Kyohei; Smyth, Mark J; Teng, Michele Wl.
Afiliação
  • Jacoberger-Foissac C; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Blake SJ; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Liu J; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • McDonald E; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Triscott H; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Nakamura K; School of Medicine, University of Queensland, Herston, Queensland, Australia.
  • Smyth MJ; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Teng MW; School of Medicine, University of Queensland, Herston, Queensland, Australia.
J Immunother Cancer ; 8(2)2020 11.
Article em En | MEDLINE | ID: mdl-33199513

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Antígenos CD40 / Antineoplásicos Imunológicos / Imunidade Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Antígenos CD40 / Antineoplásicos Imunológicos / Imunidade Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália